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Background: Delayed childbearing in European countries has resulted in an increase in the number of women
having children later in life. Thus more women face the problem of age-related infertility and cannot achieve their
desired number of children. Childbearing postponement is one of the main reasons for the increasing use of
assisted reproductive technology (ART) and conversely, the latter may be one of the factors contributing to the rise
in female childbearing age. The research goal of our article is to evaluate the demographic importance of ART
increased use and to examine its impact on both the fertility rate and birth timing.
Methods: Comparative analysis based on demographic and ART data collected by the European IVF-monitoring
(EIM) Consortium for the European Society of Human Reproduction and Embryology (ESHRE).
Results: Most countries with a higher total fertility rate (TFR) also registered a higher number of treatment cycles
per 1 million women of reproductive age. Despite the positive relationship between the postponement rate and
the demand for ART among women aged 35 and older, the highest share of children born after ART was not found
in countries characterized by a “delayed” fertility schedule. Instead, the highest proportion of ART births was found
in countries with fertility schedules concentrated on women aged between 25 and 34. Accordingly, the effective
use of ART can be expected in populations with a less advanced postponement rate.
Conclusions: ART can have a demographic relevancy when women take advantage of it earlier rather than later in
life. Furthermore it is suggested that the use of ART at a younger age increases women’s chance of achieving their
reproductive goals and reduces the risk of age-related infertility and failed ART. Based on a demographic approach,
reproductive health policy may become an integral part of policies supporting early childbearing: it may keep
women from delaying too long having children and increase the chance of diagnosing potential reproductive
health problems requiring a timely ART application.
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The reproductive behaviour of most Europeans has
shifted from an early to a late or very late childbearing
pattern [1-4]: at present women start to build a family
into their 30s or even later. In 2010 the mean age of
mothers at first childbirth was between 28 and 30 years
in EU member states [5]. On one hand, delayed child-
bearing has numerous advantages as people may be
more mature and considerate when they start a family
[4]. On the other hand, there are several severe draw-
backs that need to be addressed and studied: the longer* Correspondence: koc@natur.cuni.cz
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article, unless otherwise stated.the wait, the higher the risk of negative health outcomes
(for mother and child), the higher the risk of having to
rely on assisted reproductive technology (ART) - mainly
in vitro fertilisation (IVF) - and the higher the risk of
not achieving optimal family size.
Starting childbearing later means having less time to
achieve reproductive goals since biological limits of child-
bearing have not shifted to later ages. In addition, an in-
creasing part of reproductive plans is implemented at the
age of female fecundity decrease which may be reflected
in a perceived delay, a difficulty of conceiving or carrying
a baby to term [6]. Thus childbearing postponement has
become an issue related to female reproductive health and
is considered to be the main factor of ART increasing usentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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subfertility is often considered to be a problem easily
solved by the application of ART though it may not make
up for all lost births due to the natural decline in fertility
after the age of 35 [8].
Childbearing postponement is increasingly relevant to
demographic trends. Although most European countries
have registered a similar decrease in fertility rates of
young women, they significantly differ by the intensity of
fertility recuperation, i.e. compensatory increase in fertil-
ity rates of women at a higher age above 30 [9]. As a re-
sult, a large cross-country variation in current fertility
rates exists [5]. Accordingly, there is a tendency to re-
consider public policies related to fertility and assisted
reproductive technology (ART) support at national levels
as well as within the EU: ART policies have definitely
become much discussed topics [10]. Moreover ART treat-
ments have generated important policy questions regard-
ing their cost-effectiveness and safety [11].
ART use widely varies among European countries: des-
pite the fact that some European countries do not provide
complete statistics on ART, in 2009 the average number
of treatment cycles per 1 million inhabitants ranged from
166 in Moldova to 2726 in Denmark [12]. Since it is rather
improbable that countries would significantly differ re-
garding the share of infertile couples within their popu-
lations, the wide range in ART use may result from an
unequal access to it [13,14]. It was estimated that while
circa 3000 couples per 1 million inhabitants may be eli-
gible for ART, only half of them do request it [15,16]. Pro-
vided that each couple needs on average more than one
treatment cycle, the real need would exceed 2500 cycles.
In 2009, Denmark, Iceland, and Belgium ranked above
this estimated number while other European countries
ranked well below it. Scandinavian countries met levels of
utilization that approximated demand [13] while most
European countries have probably not met the rising need
for ART yet. However financial, medical, psychosocial,
moral or ethical grounds may distinctly affect the use of
infertility treatments in compared countries [17].
The core of our paper is not a mere cross-country
comparison of ART utilization but does focus on search-
ing for a relationship between the increased use of ART
and fertility trends. While the impact of childbearing
postponement on the fertility rate and ART demand has
been analysed and discussed [18,10,19-21], the impact of
ART increasing use on both the fertility rate and birth
timing has not been studied comprehensively. Our re-
search goal was to evaluate the demographic potential of
ART increasing use in relation to childbearing post-
ponement. Consequently ART higher use is expected in
countries with a higher fertility rate and a delayed fer-
tility pattern. Nevertheless findings are interpreted with
caution as both the fertility rate and birth timing areinfluenced by additional individual and social factors
that may play a more significant role.
Methods
The cross-national comparison of available data on ART
use in Europe has been collected by the European IVF-
monitoring (EIM) Consortium for the European Society
of Human Reproduction and Embryology (ESHRE) since
1997 and published in Human Reproduction [22-26,12].
Although data on ART have been collected by national
registers, the method of reporting varied among coun-
tries and some did not provide complete information. It
is particularly pertinent as to live births following the
use of ART due to difficulties when gathering pregnancy
outcomes: only countries with a 100% coverage - i.e. in-
cluding all clinics comprehensive participation - were in-
cluded in the analysis and are presented in Figures,
except Table 1. In Table 1, countries with a low rate of
incompleteness were taken into account as well. Table 1
provides information on structure of women treated
with IVF/ICSI by age groups while Figures present the
level of ART use where complete data are essential for
full comparability. ART includes all forms of treatments
and techniques related to the in vitro handling of both
human oocytes and sperm, or embryos, for the purpose
of creating a pregnancy [27]. ART does not include as-
sisted insemination. Available tables covered data on IVF
(in vitro fertilization), ICSI (intracytoplasmic sperm injec-
tion), FER (frozen embryo replacement), ED (oocyte dona-
tion), IVM (in vitro maturation), PGD (preimplantation
genetic diagnosis), and FOR (frozen oocyte replacement).
Differences in ART use among countries were ana-
lysed in relation to data on fertility [28]. As data on ART
births according to female age were not available, we
could merely use general indicators such as proportion
of ART births, number of treatment cycles per 1 million
women of reproductive age, and proportion of women
treated by IFV/ICSI according to age groups. In order to
analyse the relationship between increased ART use and
fertility trends, total fertility rate (TFR) and fertility post-
ponement index (FPI) counted from all births in a given
country, were taken into account. However we were
aware of shortcomings of such an approach as both the
fertility rate and the postponement rate are influenced
by individual factors as well as external factors such as
cultural values, economic factors or family policies [10].
Although merely used for a descriptive purpose, some
common tendencies regarding the link between ART use
and fertility trends could be identified across countries.
TFR is defined as the average number of live births per
woman during her lifetime, as if she were to pass through
all her childbearing years conforming to age-specific fer-
tility rates (ASFR) of a given year [29]. ASFR were used
to create fertility age schedules for selected countries
Table 1 Age structure of women treated with IVF/ICSI in selected European countries, 1997 and 2009
Country 1997 Country 2009
IVF + ICSI (%) IVF + ICSI (%)
≤34 35-39 ≥40 ≤34 35-39 ≥40
Czech Republic 63.5 27.0 9.4 Czech Republicb 67.2 25.4 7.4
Denmark NA NA NA Denmark 50.6 31.0 18.4
Finland 57.9 27.9 14.1 Finland 55.0 31.6 13.5
France 58.3 29.7 12.0 France NA NA NA
Germany 55.7 29.9 14.5 Germanyc 45.5 41.2 13.3
Hungarya 66.7 22.5 11.0 Hungary 56.3 30.1 13.6
Iceland 40.8 29.6 14.7 Iceland NA NA NA
Ireland NA NA NA Irelanda 30.8 47.2 22.0
Italy 54.3 33.2 12.5 Italy 31.3 40.5 28.2
Portugal 63.3 30.4 6.3 Portugal 49.1 39.0 12.0
Slovenia NA NA NA Slovenia 51.9 32.8 15.4
Spain 50.3 38.6 11.2 Spaina 40.9 45.9 13.2
Sweden 56.5 34.0 9.5 Sweden 49.0 39.0 11.9
Switzerland 49.1 36.1 14.8 Switzerlanda 36.6 42.8 20.5
United Kingdom 54.4 32.9 12.7 United Kingdom 41.9 40.9 17.2
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schedule: the greatest concentration of births occurring in
early 30s and a considerable amount of births occurring in
late 30s. Lesthaeghe & Niedert´s fertility postponement
index (FPI) is the ratio of the sum of ASFR above age 29
to the sum of these rates between ages 20 and 29 [30,31].
FPI was constructed to measure the postponement rate in
a simplified way. FPI of about 1.3 and more, identifies
countries with an advanced postponement rate, i.e. “de-
layed fertility pattern” while FPI at 0.8 and lower, identifies
countries with a low postponement rate, i.e. “early” fertility
pattern.
Results
Trends in ART use
Figure 1 presents ART use in countries which provi-
ded complete data at least during three years within the
period under observation. Between 1997 and 2007, all
selected countries except Iceland, experienced a continu-
ous increase in the percentage of live births following
the use of ART. However, due to an unequal rate of
increase in ART use across countries, cross-country var-
iation deepened. The highest increase in percentage of
live births following the use of ART was found in
Denmark, Belgium, Slovenia, and the Czech Republic.
The highest proportion of children born following ART
was reached in Denmark (close to 5%) in 2007. The year
2007 can be taken as a turning point particularly forcountries with a proportion exceeding 3.5%: up until
2009, all of the latter recorded a decrease or stabilization
at around the level of 4.5%, suggesting that a possible
threshold was reached. An uninterrupted increase in the
proportion of children born following ART was only
found in a few countries with a lower percentage such as
Italy (1.4% in 2009), France (1.9% in 2009) and the
United Kingdom (2% in 2009) as well as Sweden (3.5%
in 2009) and Norway (3.1% in 2009). Recently the per-
centage of children born following ART exceeded 3%
in Northern European countries, Belgium, the Czech
Republic and Slovenia.
Relationship between ART use and the fertility rate
In 1997, countries with a higher TFR reported a higher
number of treatment cycles per 1 million women of re-
productive age (see Figure 2). By 2009, the number of
treatment cycles had doubled specifically in countries that
registered TFR close to 2 children per woman (Figure 3).
Furthermore a substantial increase in ART cycles was also
relevant for countries with a low TFR, i.e. the Czech
Republic and Slovenia. In contrast to 1997, in 2009 the
Czech Republic and Slovenia reported a higher number
of treatment cycles per 1million women aged 15–45
than France and the Netherlands. Consequently, both
the Czech Republic and Slovenia experienced a significant
increase in TFR between 1997 and 2009 and the plot did
not vary significantly until 2009 as most countries with a
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Figure 1 Trends in percentage of ART births between 1997 and 2009 in selected European countries. Data sources: ESHRE, The Czech
National ART Register.
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Figure 3 European countries by TFR and ART cycles per million women aged 15–45, 2009. Data sources: ESHRE, Eurostat.
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cles per 1million women of reproductive age as well.
Trends in age structure of women treated with ART
The countries under study significantly differ according
to the age structure of women who requested IVF/ICSI
(Table 1). Variations even increased between 1997 and
2009 as the proportion of women aged 40 and over ranged
between 9% in the Czech Republic and 15% in Switzerland
in 1997, while in 2009 it was between 7% in the Czech
Republic and 28% in Italy. Interestingly, a rather signifi-
cant proportion of women who requested IVF was consti-
tuted by younger women, younger than 35. In the Czech
Republic, women younger than 35 represented almost
70% of the total number who had requested ART. More-
over, in the Czech Republic there was almost no change in
the age structure of women who had requested IVF/ICSI
between 1997 and 2007. On the contrary, most other
countries in Table 1, i.e. Italy, Switzerland, Spain, Sweden,
Germany, Portugal, and Hungary, did register quite a sig-
nificant increase in the share of women aged 35 and over.
Recently the highest share of women aged 35 and over
was found in Ireland and Italy (almost 70%). In countries
with the highest proportion of ART births, i.e. Denmark
or Slovenia, women aged 35 and over accounted for less
than 50% of the total number who had requested ART.
Relationship between the use of ART and birth timing
No direct link between the percentage of children born
following ART and the postponement rate in countries
under study was found (Figure 4). Actually the highestpercentage of children born following ART was found in
countries with a less advanced postponement rate, i.e.
with FPI between 1 and 1.2 (Slovenia and Denmark).
Furthermore, the highest postponement rate registered
in Italy has not been reflected in a high percentage of chil-
dren born following ART but the reverse is true. Figure 5
gives a more detailed picture regarding fertility age sche-
dules in these three countries. A high percentage of chil-
dren born following ART and a high TFR in Denmark are
connected with fertility schedules concentrated on women
aged between 25 and 34, i.e. with a “broad peak” fertility
pattern. Both Denmark and Slovenia have experienced a
sharp rise of fertility in early 20s and late 20s as well as a
sharp decrease in fertility from 34 onward. On the con-
trary, a low proportion of ART births and a low TFR are
connected to a “delayed” fertility pattern. Accordingly,
an effective ART use can be expected in countries with
“broad peak” fertility schedules rather than in countries
with a “delayed” fertility schedule. The increasing demand
for ART is significant among women who delay childbear-
ing and are by definition older. The positive relationship
existing – scale between the postponement rate and the
percentage of women aged 35 and older treated with IVF/
ICSI, was definitely established in countries under study
(Figure 6).
Discussion
We found out that though ART use is widespread in
countries under study, large-scale differences in its use
still prevail. The sharp increase in the number of treat-
ment cycles, particularly between 1997 and 2007, reflected
Austria 
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Figure 4 European countries by percentage of ART births and fertility postponement index, 2009. a Lesthaeghe & Niedert´s fertility
postponement index (FPI) is the ratio of the sum of ASFR above age 29 to the sum of these rates between ages 20 and 29. Data sources: ESHRE,
Eurostat, The Czech National ART Register.
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crease in the proportion of ART births was in relation to
the increase in TFR [32]. Accordingly, we suppose that re-
cent fertility recuperation trends led to the rising need of
ART treatment. Nevertheless, countries significantly dif-
fered as to the rate of increase within the proportion of
ART births.
The important determinant of ART use is state health
insurance policy [11]. Although the impact of reimburse-
ment on ART use was not the primary aim of our study,
differences in the range of public insurance coverage
among countries under study, have to be taken into
account. Denmark and Belgium seem to be leading as
to health insurance reimbursement patterns: ART in
Denmark is provided free of charge to women below
the age of 40, up to three cycles and is easily accessible at
public clinics [33]. In Belgium even up to six ART cycles
are reimbursed to women under 43 [34]. Thus both coun-
tries registered a substantial increase in the proportion of
ART births by 2007. On the contrary, Germany has de-
noted the negative impact of a more restrictive reimburse-
ment policy introduced in 2004 [35]: co-payments of ART
treatment were raised for childless couples and the num-
ber of subsidized treatments limited to three. As a result,
Germany has remained among countries with a low ART
use. ART use demographic potential seems to become in-
creasingly dependent on state supportive policies of ART
Thus at the level of ART affordability to the public. This
has become particularly evident since 2008 when dueto the economic recession, massive cuts in public spen-
ding reduced state family-related expenditures and
consequently also fertility decision making [36]. A discon-
tinuation of the increase in the proportion of ART births
was registered particularly in countries where the previous
TFR upturn had been replaced by its stagnation or de-
cline, i.e. in Denmark, Slovenia, Belgium, Finland and
Germany. While in Denmark or Belgium a threshold in
the use of ART was probably reached prior to 2008, other
countries such as Germany had not yet fully utilized ART
potential and a stimulation of the increase in ART use
would need additional investments.
Our results indicate that the growing utilization of
ART has become relevant when assessing recent fertility
trends. Some recent studies documented that the poten-
tial contribution of ART to rising fertility rates was not
negligible [37-40]. Despite the limits in the increase of
ART use, its impact on the fertility level could be sig-
nificant particularly in countries with TFR below 1.5 [41]
although most studies overestimated the effectiveness of
ART or neglected biological and behavioural factors
when assessing its true effect [10], It is suggested that
ART support become an integral part of national stra-
tegies addressing demographic and reproductive chal-
lenges [42]. However in reality, it is clearly exceptional
since only Denmark’s reimbursement scheme has been
influenced by demographic concerns so far [43]. An ex-
plicit ART policy based on goals different from demogra-
























Figure 5 Proportion of ASFRs on TFR in%, Denmark, Slovenia, Italy, 2009. Data source: Eurostat.
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Indeed, taking Belgium as an example, a well-founded
strategy meant to improve access to ART treatment based
on the aim of supporting the birth of a healthy singleton
child, could have a demographic impact.
A considerable change in birth timing is the key de-
mographic aspect related to ART use which then, may
go against the endeavour to enhance state support to
ART. It was argued that ART increased availability might
create a false perception among the public that child-
bearing could be postponed until late reproductive age
groups - ART making pregnancy possible for almost any
prospective mother [40]. Our results do suggest that the
increasing prevalence of women aged 35 and over among
all women who asked for IVF/ICSI, has been undoubtedly
part of the effect of childbearing postponement. However,
the age structure of women treated with IVF/ISCI is youn-
ger in Denmark than in the United Kingdom although
ART is more subsidized in Denmark. Instead, ART better
availability might encourage couples to seek help sooner
rather than later.
Nevertheless, besides ART reimbursement policy ad-
ditional factors have to be taken into account whenexplaining differences in age structures of women treated
with IVF/ICSI. Firstly, guidelines related to “the waiting
period” before applying for IFV when attempts to con-
ceive naturally failed, may vary from one year in the Czech
Republic [44] to three years in the Netherlands [45]. Sec-
ondly, the number of cycles and the female age limit for
reimbursement can play a role within the well-timed deci-
sion making process. Probably, the low number of reim-
bursed cycles coupled with the female low age limit as it is
in the Czech Republic - up to three cycles until the age of
39 [44] - would stimulate women to ask for an ART treat-
ment earlier in their lifetime so as to have a better chance
at succeeding, compared to Belgium where women under
43 are entitled up to six reimbursed cycles [43]. Accord-
ingly the Czech Republic has maintained the youngest fe-
male age structure treated with IVF/ICSI despite the trend
towards postponement.
While increased ART use is considered to be the result
of childbearing postponement, we found out that it
need not contribute to delayed childbearing, i.e. to the in-
creased mean age of mothers at childbirth. Moreover,
trends towards a rectangularization of fertility, i.e. re-
duction of variability of mothers’ age at first birth and
Denmark  
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Figure 6 European countries by percentage of women 35+ treated with IVF/ICSI and fertility postponement index, 2009. a Lesthaeghe
& Niedert´s fertility postponement index (FPI) is the ratio of the sum of ASFR above age 29 to the sum of these rates between ages 20 and 29. Data
sources: ESHRE, Eurostat.
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have not been discerned [46]. Our results indicated that
the demographic relevancy of ART use is more common
in a population with a less advanced postponement
rate. It supports previous findings about the import-
ance of ART contribution to fertility rates of women
currently in the middle of their reproductive span [40].
Although the increase in the proportion of women aged
35 and over among those who requested ART was
established, the relevant higher fertility rates of women
aged 35 and over were not apparent. As ART success
rate dramatically decreases with women aged 35 and
over, an increasing ART use does not significantly con-
tribute to the increase in female age at childbirth. A
more intense childbearing postponement could prob-
ably develop if ART success rates significantly im-
prove among late childbearing age groups. Currently,
increased ART use is expected to have a demographic
impact if women take advantage of it earlier rather than
later in life. Moreover, women who may have been able
to conceive with a less aggressive therapy, may request
ART earlier in states with a comprehensive insurance
policy [47].
Although we want to contribute to a better under-
standing of demographic relevancy of increased ART
use, we are definitely aware of the limits of our findings
as we focus exclusively on ART. A fertility increase may
be the result of diverse types of infertility treatments. In
contrast to our results, the implementation of insurancecoverage of infertility treatment including IVF in the US,
increased first birth rates for women 35 and older [48].
However, findings are not fully comparable particularly
due to the use of different data. While we concentrated
on studying the relationship between ART use and fer-
tility trends from a cross-country perspective, in the
US the effects of insurance mandates on fertility were
analysed for the period 1981–1999 using data on births.
Moreover, women who are older and highly educated
are more likely to be affected by mandates due to their
higher probability of having private health insurance [48].Conclusions
Findings for some European countries suggest that in-
creased ART use may have a demographic relevancy when
women take advantage of it earlier rather than later in life.
ART widespread use may become one of the factors keep-
ing the fertility rate stable in the future regardless of nega-
tive trends. Accordingly, it is suggested that the use of
ART at a younger age should be supported so as to in-
crease the chance of women to achieve their reproductive
goals while reducing the risk of age-related infertility and
failed ART. An ART reimbursement policy could be part
of a reproductive health policy promoting early child-
bearing: it could keep women from delaying having chil-
dren and increase the chance of diagnosing potential
reproductive health problems requiring a timely ART
application.
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